Success Metrics

Completion Rate
0%(0/1)
Active Trials
1(33%)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Terminated(1)

Detailed Status

Terminated1
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
0.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

terminated133%
recruiting133%
not_yet_recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
not_yet_recruitingnot_applicable

Safety and Feasibility of Transcatheter Injectable Hydrogel in Acute STEMI Reperfusion Injury (REFINE Study)

NCT07601997
recruiting

Preoperative vs. Pathologic Size in Breast Cancer: A Prospective Study

NCT06505577
terminated

Comparison Between NICOM-Cheetah and Flotrac-Vigileo for Cardiac Output Monitoring.

NCT03394768

Clinical Trials (3)

Showing 3 of 3 trials
NCT07601997Not Applicable

Safety and Feasibility of Transcatheter Injectable Hydrogel in Acute STEMI Reperfusion Injury (REFINE Study)

Not Yet Recruiting
NCT06505577

Preoperative vs. Pathologic Size in Breast Cancer: A Prospective Study

Recruiting
NCT03394768

Comparison Between NICOM-Cheetah and Flotrac-Vigileo for Cardiac Output Monitoring.

Terminated

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3